MMR

(redirected from MMR II)
Also found in: Dictionary, Financial, Encyclopedia.
Related to MMR II: Varivax

MMR

Farlex Partner Medical Dictionary © Farlex 2012

MMR

Abbreviation for:
masseter muscle rigidity
maternal mortality rate
measles, mumps and rubella (immunisation) (Medspeak-UK) 
Medication Management Review (Australia)
megacornea-mental retardation syndrome
mildly mentally retarded
mismatch repair
mouth-to-mouth resuscitation
mutation in mismatch repair
myocardial metabolic rate
Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved.

Patient discussion about MMR

Q. Do you know about Autism and Vaccinations? Dr. Andrew Wakefield, a famous doctor for children at the Royal Free Hospital in London made in 1998 following report...

A. this is not true!!!! as you can check in this quote from the Cochrane library:
"Measles, mumps and rubella are three very dangerous infectious diseases which cause a heavy disease, disability and death burden in the developing world. Researchers from the Cochrane Vaccines Field reviewed 139 studies conducted to assess the effects of the live attenuated combined vaccine to prevent measles, mumps and rubella (MMR) in children. MMR protects children against infections of the upper airways but very rarely may cause a benign form of bleeding under the skin and milder forms of measles, mumps and rubella. NO CREDIBLE EVIDENCE of an involvement of MMR with either autism or Crohn's disease was found. No field studies of the vaccine's effectiveness were found but the impact of mass immunisation on the elimination of the diseases has been demonstrated worldwide."

More discussions about MMR
This content is provided by iMedix and is subject to iMedix Terms. The Questions and Answers are not endorsed or recommended and are made available by patients, not doctors.
References in periodicals archive ?
The FDA approved the quadrivalent vaccine for children between the ages of 12 months and 12 years, including those in need of a second dose of the MMR II vaccine.
Because the recommendation for MMR II has been to give two doses--the first at age 12-15 months and the second prior to school entry at age 4-6 year--adoption of the quadrivalent vaccine would make the ongoing debate over the need for a second dose of the varicella vaccine irrelevant, said Richard K.
Because the recommendation for MMR II has been to give two doses--the first at age 12-15 months and the second prior to school entry at age 4-6 years--adoption of the quadrivalent vaccine would make the ongoing debate over the need for a second dose of the varicella vaccine irrelevant, said Richard K.
Vernon, executive director of scientific and public health policy for Merck's vaccine division, West Point, Pa., reported data passively gathered by the company, which makes both MMR II and Varivax.
The gelatin used in MMR II and Varivax is a highly hydrolyzed porcine gelatin.